Anti-CD112R compositions and methods
US12162941B2 · kind B2 · utility
0Cited by
34References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 19, 2021 |
| Grant date | Dec 10, 2024 |
| Priority date | — |
| Expiry date | Jan 1, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides anti-CD112R antibody compositions and their use in treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.